ESTRELLA IMMUNOPHARMA, INC. ANNOUNCES $8.0 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

Reuters · 6d ago

Please log in to view news